dc.contributor.author | Mueller-Ohldach, Mathis | |
dc.contributor.author | Kramer, Alwin | |
dc.contributor.author | Scarato, Jeremy | |
dc.contributor.author | Thomas, Marlene | |
dc.contributor.author | Moch, Holger | |
dc.contributor.author | Pauli, Chantal | |
dc.contributor.author | Bochtler, Tilmann | |
dc.contributor.author | Mileshkin, Linda | |
dc.contributor.author | Baciarello, Giulia | |
dc.contributor.author | Losa, Ferran | |
dc.contributor.author | Ross, Jeffrey S. | |
dc.contributor.author | Pentheroudakis, George | |
dc.contributor.author | Zarkavelis, George | |
dc.contributor.author | YALÇIN, ŞUAYİB | |
dc.contributor.author | ÖZGÜROĞLU, Mustafa | |
dc.contributor.author | Beringer, Andreas | |
dc.date.accessioned | 2021-12-10T09:37:57Z | |
dc.date.available | 2021-12-10T09:37:57Z | |
dc.identifier.citation | Pauli C., Bochtler T., Mileshkin L., Baciarello G., Losa F., Ross J. S. , Pentheroudakis G., Zarkavelis G., YALÇIN Ş., ÖZGÜROĞLU M., et al., "A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience", ONCOLOGIST, 2021 | |
dc.identifier.issn | 1083-7159 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_08376c29-3f24-4780-bf35-3f783b49911e | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/168139 | |
dc.identifier.uri | https://doi.org/10.1002/onco.13744 | |
dc.description.abstract | Background CUPISCO is an ongoing randomized phase II trial (NCT03498521) comparing molecularly guided therapy versus platinum-based chemotherapy in patients newly diagnosed with "unfavorable" cancer of unknown primary (CUP). | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Oncology | |
dc.subject | Health Sciences | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience | |
dc.type | Makale | |
dc.relation.journal | ONCOLOGIST | |
dc.contributor.department | Universitaet Zürich (University Of Zürich) , , | |
dc.contributor.firstauthorID | 2607015 | |